WE are delighted to announce the creation of a new Journal as part of the Human Gene Therapy portfolio called Human Gene Therapy Clinical Development. This Journal will serve as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products. Dr. Barry Byrne has agreed to participate in the launch and management of this new journal as Editor of HGT Clinical Development and the newest member of our editorial leadership team.
展开▼